nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—CYP3A5—prostate cancer	0.216	0.698	CbGaD
Saxagliptin—CYP3A4—prostate cancer	0.0935	0.302	CbGaD
Saxagliptin—ABCC1—Abiraterone—prostate cancer	0.0715	0.154	CbGbCtD
Saxagliptin—ABCC1—Conjugated Estrogens—prostate cancer	0.0338	0.0726	CbGbCtD
Saxagliptin—ABCC1—Mitoxantrone—prostate cancer	0.0307	0.066	CbGbCtD
Saxagliptin—CYP3A5—Flutamide—prostate cancer	0.0265	0.0569	CbGbCtD
Saxagliptin—SLC22A8—Conjugated Estrogens—prostate cancer	0.0263	0.0565	CbGbCtD
Saxagliptin—ABCC1—Epirubicin—prostate cancer	0.0249	0.0534	CbGbCtD
Saxagliptin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0238	0.051	CbGbCtD
Saxagliptin—SLC22A8—Estradiol—prostate cancer	0.0231	0.0496	CbGbCtD
Saxagliptin—CYP3A5—Cabazitaxel—prostate cancer	0.0196	0.0421	CbGbCtD
Saxagliptin—ABCC1—Etoposide—prostate cancer	0.0194	0.0416	CbGbCtD
Saxagliptin—CYP3A5—Estrone—prostate cancer	0.0192	0.0412	CbGbCtD
Saxagliptin—ABCC1—Docetaxel—prostate cancer	0.0177	0.0381	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—prostate cancer	0.0132	0.0284	CbGbCtD
Saxagliptin—CYP3A4—Bicalutamide—prostate cancer	0.0125	0.0268	CbGbCtD
Saxagliptin—CYP3A4—Estramustine—prostate cancer	0.0116	0.0249	CbGbCtD
Saxagliptin—CYP3A5—Estradiol—prostate cancer	0.011	0.0236	CbGbCtD
Saxagliptin—CYP3A4—Abiraterone—prostate cancer	0.0103	0.0222	CbGbCtD
Saxagliptin—CYP3A4—Flutamide—prostate cancer	0.0103	0.0222	CbGbCtD
Saxagliptin—CYP3A4—Cabazitaxel—prostate cancer	0.00765	0.0164	CbGbCtD
Saxagliptin—CYP3A4—Estrone—prostate cancer	0.00748	0.016	CbGbCtD
Saxagliptin—CYP3A5—Etoposide—prostate cancer	0.00719	0.0154	CbGbCtD
Saxagliptin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00666	0.0143	CbGbCtD
Saxagliptin—CYP3A5—Docetaxel—prostate cancer	0.00658	0.0141	CbGbCtD
Saxagliptin—CYP3A4—Conjugated Estrogens—prostate cancer	0.00489	0.0105	CbGbCtD
Saxagliptin—DPP9—prostate gland—prostate cancer	0.00481	0.0938	CbGeAlD
Saxagliptin—CYP3A4—Mitoxantrone—prostate cancer	0.00445	0.00954	CbGbCtD
Saxagliptin—DPP8—prostate gland—prostate cancer	0.00438	0.0853	CbGeAlD
Saxagliptin—CYP3A4—Estradiol—prostate cancer	0.00429	0.00922	CbGbCtD
Saxagliptin—DPP8—seminal vesicle—prostate cancer	0.00371	0.0722	CbGeAlD
Saxagliptin—CYP3A4—Prednisone—prostate cancer	0.00369	0.00793	CbGbCtD
Saxagliptin—SLC22A8—urine—prostate cancer	0.00337	0.0657	CbGeAlD
Saxagliptin—DPP8—urethra—prostate cancer	0.00293	0.0571	CbGeAlD
Saxagliptin—CYP3A4—Etoposide—prostate cancer	0.0028	0.00602	CbGbCtD
Saxagliptin—CYP3A4—Docetaxel—prostate cancer	0.00256	0.00551	CbGbCtD
Saxagliptin—SLCO4C1—seminal vesicle—prostate cancer	0.00235	0.0457	CbGeAlD
Saxagliptin—DPP8—bone marrow—prostate cancer	0.00226	0.044	CbGeAlD
Saxagliptin—DPP9—testis—prostate cancer	0.00212	0.0413	CbGeAlD
Saxagliptin—DPP8—testis—prostate cancer	0.00193	0.0376	CbGeAlD
Saxagliptin—CYP3A4—Doxorubicin—prostate cancer	0.00191	0.0041	CbGbCtD
Saxagliptin—SLCO4C1—renal system—prostate cancer	0.00189	0.0368	CbGeAlD
Saxagliptin—DPP4—prostate gland—prostate cancer	0.00184	0.0359	CbGeAlD
Saxagliptin—CYP3A4—urine—prostate cancer	0.00167	0.0326	CbGeAlD
Saxagliptin—DPP4—seminal vesicle—prostate cancer	0.00156	0.0303	CbGeAlD
Saxagliptin—DPP9—lymph node—prostate cancer	0.00154	0.0299	CbGeAlD
Saxagliptin—SLCO4C1—bone marrow—prostate cancer	0.00143	0.0278	CbGeAlD
Saxagliptin—DPP8—lymph node—prostate cancer	0.0014	0.0273	CbGeAlD
Saxagliptin—DPP4—epithelium—prostate cancer	0.00135	0.0263	CbGeAlD
Saxagliptin—DPP4—renal system—prostate cancer	0.00125	0.0244	CbGeAlD
Saxagliptin—SLC22A8—prostate gland—prostate cancer	0.00121	0.0236	CbGeAlD
Saxagliptin—ABCC1—prostate gland—prostate cancer	0.00104	0.0203	CbGeAlD
Saxagliptin—DPP4—bone marrow—prostate cancer	0.000949	0.0185	CbGeAlD
Saxagliptin—ABCC1—seminal vesicle—prostate cancer	0.00088	0.0171	CbGeAlD
Saxagliptin—SLC22A8—renal system—prostate cancer	0.000826	0.0161	CbGeAlD
Saxagliptin—DPP4—testis—prostate cancer	0.000811	0.0158	CbGeAlD
Saxagliptin—CYP3A5—prostate gland—prostate cancer	0.0008	0.0156	CbGeAlD
Saxagliptin—ABCC1—urethra—prostate cancer	0.000697	0.0136	CbGeAlD
Saxagliptin—DPP4—lymph node—prostate cancer	0.000588	0.0114	CbGeAlD
Saxagliptin—CYP3A5—renal system—prostate cancer	0.000545	0.0106	CbGeAlD
Saxagliptin—ABCC1—testis—prostate cancer	0.000459	0.00893	CbGeAlD
Saxagliptin—CYP3A4—renal system—prostate cancer	0.000409	0.00797	CbGeAlD
Saxagliptin—ABCC1—lymph node—prostate cancer	0.000332	0.00647	CbGeAlD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000144	0.0012	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Goserelin—prostate cancer	0.000144	0.0012	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000142	0.00119	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000142	0.00118	CcSEcCtD
Saxagliptin—Dizziness—Ethinyl Estradiol—prostate cancer	0.000141	0.00118	CcSEcCtD
Saxagliptin—Infestation NOS—Docetaxel—prostate cancer	0.000141	0.00117	CcSEcCtD
Saxagliptin—Infestation—Docetaxel—prostate cancer	0.000141	0.00117	CcSEcCtD
Saxagliptin—Urticaria—Goserelin—prostate cancer	0.00014	0.00116	CcSEcCtD
Saxagliptin—Anaphylactic shock—Estradiol—prostate cancer	0.000139	0.00116	CcSEcCtD
Saxagliptin—Abdominal pain—Goserelin—prostate cancer	0.000139	0.00116	CcSEcCtD
Saxagliptin—Infection—Estradiol—prostate cancer	0.000138	0.00115	CcSEcCtD
Saxagliptin—Urticaria—Conjugated Estrogens—prostate cancer	0.000138	0.00115	CcSEcCtD
Saxagliptin—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000138	0.00115	CcSEcCtD
Saxagliptin—Immune system disorder—Etoposide—prostate cancer	0.000137	0.00115	CcSEcCtD
Saxagliptin—Infestation NOS—Capecitabine—prostate cancer	0.000136	0.00114	CcSEcCtD
Saxagliptin—Infestation—Capecitabine—prostate cancer	0.000136	0.00114	CcSEcCtD
Saxagliptin—Vomiting—Ethinyl Estradiol—prostate cancer	0.000136	0.00113	CcSEcCtD
Saxagliptin—Arthralgia—Mitoxantrone—prostate cancer	0.000135	0.00113	CcSEcCtD
Saxagliptin—Myalgia—Mitoxantrone—prostate cancer	0.000135	0.00113	CcSEcCtD
Saxagliptin—Skin disorder—Estradiol—prostate cancer	0.000135	0.00113	CcSEcCtD
Saxagliptin—Rash—Ethinyl Estradiol—prostate cancer	0.000135	0.00112	CcSEcCtD
Saxagliptin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000134	0.00112	CcSEcCtD
Saxagliptin—Headache—Ethinyl Estradiol—prostate cancer	0.000134	0.00112	CcSEcCtD
Saxagliptin—Pancreatitis—Prednisone—prostate cancer	0.000133	0.00111	CcSEcCtD
Saxagliptin—Urinary tract infection—Capecitabine—prostate cancer	0.000132	0.0011	CcSEcCtD
Saxagliptin—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00013	0.00108	CcSEcCtD
Saxagliptin—Hypersensitivity—Goserelin—prostate cancer	0.000129	0.00108	CcSEcCtD
Saxagliptin—Infection—Mitoxantrone—prostate cancer	0.000129	0.00108	CcSEcCtD
Saxagliptin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000128	0.00107	CcSEcCtD
Saxagliptin—Purpura—Epirubicin—prostate cancer	0.000128	0.00107	CcSEcCtD
Saxagliptin—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000127	0.00106	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000127	0.00106	CcSEcCtD
Saxagliptin—Nausea—Ethinyl Estradiol—prostate cancer	0.000127	0.00106	CcSEcCtD
Saxagliptin—Hypoglycaemia—Epirubicin—prostate cancer	0.000126	0.00105	CcSEcCtD
Saxagliptin—Asthenia—Goserelin—prostate cancer	0.000126	0.00105	CcSEcCtD
Saxagliptin—Skin disorder—Mitoxantrone—prostate cancer	0.000126	0.00105	CcSEcCtD
Saxagliptin—Erectile dysfunction—Prednisone—prostate cancer	0.000125	0.00105	CcSEcCtD
Saxagliptin—Asthenia—Conjugated Estrogens—prostate cancer	0.000125	0.00104	CcSEcCtD
Saxagliptin—Oedema peripheral—Docetaxel—prostate cancer	0.000124	0.00104	CcSEcCtD
Saxagliptin—Pruritus—Goserelin—prostate cancer	0.000124	0.00104	CcSEcCtD
Saxagliptin—Pruritus—Conjugated Estrogens—prostate cancer	0.000123	0.00103	CcSEcCtD
Saxagliptin—Dyspepsia—Estradiol—prostate cancer	0.000123	0.00102	CcSEcCtD
Saxagliptin—Oedema peripheral—Capecitabine—prostate cancer	0.00012	0.001	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Estradiol—prostate cancer	0.00012	0.001	CcSEcCtD
Saxagliptin—Fatigue—Estradiol—prostate cancer	0.00012	0.001	CcSEcCtD
Saxagliptin—Face oedema—Epirubicin—prostate cancer	0.000119	0.000992	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000118	0.000987	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—prostate cancer	0.000118	0.000986	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—prostate cancer	0.000117	0.000974	CcSEcCtD
Saxagliptin—Dizziness—Goserelin—prostate cancer	0.000116	0.000969	CcSEcCtD
Saxagliptin—Blood creatinine increased—Epirubicin—prostate cancer	0.000115	0.000962	CcSEcCtD
Saxagliptin—Dizziness—Conjugated Estrogens—prostate cancer	0.000115	0.00096	CcSEcCtD
Saxagliptin—Dyspepsia—Mitoxantrone—prostate cancer	0.000114	0.000953	CcSEcCtD
Saxagliptin—Immune system disorder—Docetaxel—prostate cancer	0.000114	0.000952	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Estradiol—prostate cancer	0.000114	0.00095	CcSEcCtD
Saxagliptin—Fatigue—Mitoxantrone—prostate cancer	0.000112	0.000934	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000112	0.000933	CcSEcCtD
Saxagliptin—Vomiting—Goserelin—prostate cancer	0.000112	0.000932	CcSEcCtD
Saxagliptin—Rash—Goserelin—prostate cancer	0.000111	0.000924	CcSEcCtD
Saxagliptin—Dermatitis—Goserelin—prostate cancer	0.000111	0.000923	CcSEcCtD
Saxagliptin—Vomiting—Conjugated Estrogens—prostate cancer	0.000111	0.000923	CcSEcCtD
Saxagliptin—Urticaria—Estradiol—prostate cancer	0.000111	0.000923	CcSEcCtD
Saxagliptin—Immune system disorder—Capecitabine—prostate cancer	0.00011	0.000921	CcSEcCtD
Saxagliptin—Abdominal pain—Estradiol—prostate cancer	0.00011	0.000919	CcSEcCtD
Saxagliptin—Nasopharyngitis—Epirubicin—prostate cancer	0.00011	0.000919	CcSEcCtD
Saxagliptin—Headache—Goserelin—prostate cancer	0.00011	0.000918	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—prostate cancer	0.00011	0.000918	CcSEcCtD
Saxagliptin—Malnutrition—Docetaxel—prostate cancer	0.00011	0.000917	CcSEcCtD
Saxagliptin—Rash—Conjugated Estrogens—prostate cancer	0.00011	0.000916	CcSEcCtD
Saxagliptin—Dermatitis—Conjugated Estrogens—prostate cancer	0.00011	0.000915	CcSEcCtD
Saxagliptin—Headache—Conjugated Estrogens—prostate cancer	0.000109	0.00091	CcSEcCtD
Saxagliptin—Gastritis—Epirubicin—prostate cancer	0.000109	0.000909	CcSEcCtD
Saxagliptin—Anaphylactic shock—Etoposide—prostate cancer	0.000108	0.000901	CcSEcCtD
Saxagliptin—Infection—Etoposide—prostate cancer	0.000107	0.000895	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—prostate cancer	0.000107	0.00089	CcSEcCtD
Saxagliptin—Malnutrition—Capecitabine—prostate cancer	0.000106	0.000888	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000106	0.000885	CcSEcCtD
Saxagliptin—Thrombocytopenia—Etoposide—prostate cancer	0.000106	0.000882	CcSEcCtD
Saxagliptin—Flatulence—Capecitabine—prostate cancer	0.000105	0.000875	CcSEcCtD
Saxagliptin—Skin disorder—Etoposide—prostate cancer	0.000105	0.000875	CcSEcCtD
Saxagliptin—Nausea—Goserelin—prostate cancer	0.000104	0.000871	CcSEcCtD
Saxagliptin—Pancreatitis—Epirubicin—prostate cancer	0.000104	0.00087	CcSEcCtD
Saxagliptin—Nausea—Conjugated Estrogens—prostate cancer	0.000103	0.000862	CcSEcCtD
Saxagliptin—Urticaria—Mitoxantrone—prostate cancer	0.000103	0.00086	CcSEcCtD
Saxagliptin—Hypersensitivity—Estradiol—prostate cancer	0.000103	0.000856	CcSEcCtD
Saxagliptin—Abdominal pain—Mitoxantrone—prostate cancer	0.000103	0.000856	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—prostate cancer	0.000102	0.00085	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—prostate cancer	0.000101	0.000841	CcSEcCtD
Saxagliptin—Asthenia—Estradiol—prostate cancer	9.99e-05	0.000834	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Epirubicin—prostate cancer	9.89e-05	0.000825	CcSEcCtD
Saxagliptin—Pruritus—Estradiol—prostate cancer	9.85e-05	0.000822	CcSEcCtD
Saxagliptin—Immune system disorder—Prednisone—prostate cancer	9.83e-05	0.000821	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—prostate cancer	9.65e-05	0.000805	CcSEcCtD
Saxagliptin—Hypersensitivity—Mitoxantrone—prostate cancer	9.56e-05	0.000798	CcSEcCtD
Saxagliptin—Infestation NOS—Epirubicin—prostate cancer	9.48e-05	0.000792	CcSEcCtD
Saxagliptin—Infestation—Epirubicin—prostate cancer	9.48e-05	0.000792	CcSEcCtD
Saxagliptin—Malnutrition—Prednisone—prostate cancer	9.48e-05	0.000791	CcSEcCtD
Saxagliptin—Arthralgia—Docetaxel—prostate cancer	9.35e-05	0.000781	CcSEcCtD
Saxagliptin—Myalgia—Docetaxel—prostate cancer	9.35e-05	0.000781	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Etoposide—prostate cancer	9.32e-05	0.000778	CcSEcCtD
Saxagliptin—Asthenia—Mitoxantrone—prostate cancer	9.31e-05	0.000777	CcSEcCtD
Saxagliptin—Fatigue—Etoposide—prostate cancer	9.3e-05	0.000777	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	9.29e-05	0.000775	CcSEcCtD
Saxagliptin—Urinary tract infection—Epirubicin—prostate cancer	9.22e-05	0.000769	CcSEcCtD
Saxagliptin—Dizziness—Estradiol—prostate cancer	9.21e-05	0.000768	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—prostate cancer	9.15e-05	0.000763	CcSEcCtD
Saxagliptin—Arthralgia—Capecitabine—prostate cancer	9.06e-05	0.000756	CcSEcCtD
Saxagliptin—Myalgia—Capecitabine—prostate cancer	9.06e-05	0.000756	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	8.99e-05	0.000751	CcSEcCtD
Saxagliptin—Anaphylactic shock—Docetaxel—prostate cancer	8.97e-05	0.000749	CcSEcCtD
Saxagliptin—Infection—Docetaxel—prostate cancer	8.91e-05	0.000744	CcSEcCtD
Saxagliptin—Sinusitis—Epirubicin—prostate cancer	8.9e-05	0.000743	CcSEcCtD
Saxagliptin—Vomiting—Estradiol—prostate cancer	8.85e-05	0.000739	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Etoposide—prostate cancer	8.82e-05	0.000736	CcSEcCtD
Saxagliptin—Thrombocytopenia—Docetaxel—prostate cancer	8.78e-05	0.000733	CcSEcCtD
Saxagliptin—Rash—Estradiol—prostate cancer	8.78e-05	0.000733	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—prostate cancer	8.78e-05	0.000732	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—prostate cancer	8.78e-05	0.000732	CcSEcCtD
Saxagliptin—Dermatitis—Estradiol—prostate cancer	8.77e-05	0.000732	CcSEcCtD
Saxagliptin—Headache—Estradiol—prostate cancer	8.72e-05	0.000728	CcSEcCtD
Saxagliptin—Skin disorder—Docetaxel—prostate cancer	8.71e-05	0.000727	CcSEcCtD
Saxagliptin—Angioedema—Prednisone—prostate cancer	8.66e-05	0.000723	CcSEcCtD
Saxagliptin—Infection—Capecitabine—prostate cancer	8.63e-05	0.00072	CcSEcCtD
Saxagliptin—Urticaria—Etoposide—prostate cancer	8.57e-05	0.000716	CcSEcCtD
Saxagliptin—Abdominal pain—Etoposide—prostate cancer	8.53e-05	0.000712	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—prostate cancer	8.53e-05	0.000712	CcSEcCtD
Saxagliptin—Thrombocytopenia—Capecitabine—prostate cancer	8.5e-05	0.00071	CcSEcCtD
Saxagliptin—Skin disorder—Capecitabine—prostate cancer	8.43e-05	0.000704	CcSEcCtD
Saxagliptin—Oedema peripheral—Epirubicin—prostate cancer	8.39e-05	0.0007	CcSEcCtD
Saxagliptin—Nausea—Estradiol—prostate cancer	8.27e-05	0.00069	CcSEcCtD
Saxagliptin—Vomiting—Mitoxantrone—prostate cancer	8.25e-05	0.000688	CcSEcCtD
Saxagliptin—Sinusitis—Doxorubicin—prostate cancer	8.23e-05	0.000687	CcSEcCtD
Saxagliptin—Rash—Mitoxantrone—prostate cancer	8.18e-05	0.000683	CcSEcCtD
Saxagliptin—Dermatitis—Mitoxantrone—prostate cancer	8.17e-05	0.000682	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.17e-05	0.000682	CcSEcCtD
Saxagliptin—Headache—Mitoxantrone—prostate cancer	8.13e-05	0.000678	CcSEcCtD
Saxagliptin—Arthralgia—Prednisone—prostate cancer	8.07e-05	0.000673	CcSEcCtD
Saxagliptin—Myalgia—Prednisone—prostate cancer	8.07e-05	0.000673	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.01e-05	0.000669	CcSEcCtD
Saxagliptin—Hypersensitivity—Etoposide—prostate cancer	7.95e-05	0.000664	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.91e-05	0.00066	CcSEcCtD
Saxagliptin—Dyspepsia—Docetaxel—prostate cancer	7.89e-05	0.000659	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—prostate cancer	7.76e-05	0.000648	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Docetaxel—prostate cancer	7.74e-05	0.000646	CcSEcCtD
Saxagliptin—Asthenia—Etoposide—prostate cancer	7.74e-05	0.000646	CcSEcCtD
Saxagliptin—Anaphylactic shock—Prednisone—prostate cancer	7.73e-05	0.000646	CcSEcCtD
Saxagliptin—Fatigue—Docetaxel—prostate cancer	7.73e-05	0.000645	CcSEcCtD
Saxagliptin—Nausea—Mitoxantrone—prostate cancer	7.71e-05	0.000643	CcSEcCtD
Saxagliptin—Immune system disorder—Epirubicin—prostate cancer	7.69e-05	0.000642	CcSEcCtD
Saxagliptin—Infection—Prednisone—prostate cancer	7.68e-05	0.000641	CcSEcCtD
Saxagliptin—Dyspepsia—Capecitabine—prostate cancer	7.64e-05	0.000638	CcSEcCtD
Saxagliptin—Pruritus—Etoposide—prostate cancer	7.63e-05	0.000637	CcSEcCtD
Saxagliptin—Skin disorder—Prednisone—prostate cancer	7.51e-05	0.000627	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Capecitabine—prostate cancer	7.5e-05	0.000626	CcSEcCtD
Saxagliptin—Fatigue—Capecitabine—prostate cancer	7.49e-05	0.000625	CcSEcCtD
Saxagliptin—Malnutrition—Epirubicin—prostate cancer	7.41e-05	0.000619	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Docetaxel—prostate cancer	7.33e-05	0.000612	CcSEcCtD
Saxagliptin—Flatulence—Epirubicin—prostate cancer	7.3e-05	0.00061	CcSEcCtD
Saxagliptin—Dizziness—Etoposide—prostate cancer	7.14e-05	0.000596	CcSEcCtD
Saxagliptin—Immune system disorder—Doxorubicin—prostate cancer	7.12e-05	0.000594	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Capecitabine—prostate cancer	7.1e-05	0.000593	CcSEcCtD
Saxagliptin—Abdominal pain—Docetaxel—prostate cancer	7.09e-05	0.000592	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Prednisone—prostate cancer	7.05e-05	0.000588	CcSEcCtD
Saxagliptin—Urticaria—Capecitabine—prostate cancer	6.9e-05	0.000576	CcSEcCtD
Saxagliptin—Abdominal pain—Capecitabine—prostate cancer	6.86e-05	0.000573	CcSEcCtD
Saxagliptin—Vomiting—Etoposide—prostate cancer	6.86e-05	0.000573	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—prostate cancer	6.86e-05	0.000572	CcSEcCtD
Saxagliptin—Dyspepsia—Prednisone—prostate cancer	6.81e-05	0.000568	CcSEcCtD
Saxagliptin—Rash—Etoposide—prostate cancer	6.8e-05	0.000568	CcSEcCtD
Saxagliptin—Dermatitis—Etoposide—prostate cancer	6.8e-05	0.000567	CcSEcCtD
Saxagliptin—Headache—Etoposide—prostate cancer	6.76e-05	0.000564	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—prostate cancer	6.76e-05	0.000564	CcSEcCtD
Saxagliptin—Fatigue—Prednisone—prostate cancer	6.67e-05	0.000557	CcSEcCtD
Saxagliptin—Hypersensitivity—Docetaxel—prostate cancer	6.61e-05	0.000551	CcSEcCtD
Saxagliptin—Asthenia—Docetaxel—prostate cancer	6.43e-05	0.000537	CcSEcCtD
Saxagliptin—Nausea—Etoposide—prostate cancer	6.41e-05	0.000535	CcSEcCtD
Saxagliptin—Hypersensitivity—Capecitabine—prostate cancer	6.4e-05	0.000534	CcSEcCtD
Saxagliptin—Pruritus—Docetaxel—prostate cancer	6.34e-05	0.00053	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Prednisone—prostate cancer	6.32e-05	0.000528	CcSEcCtD
Saxagliptin—Arthralgia—Epirubicin—prostate cancer	6.31e-05	0.000527	CcSEcCtD
Saxagliptin—Myalgia—Epirubicin—prostate cancer	6.31e-05	0.000527	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.27e-05	0.000523	CcSEcCtD
Saxagliptin—Asthenia—Capecitabine—prostate cancer	6.23e-05	0.00052	CcSEcCtD
Saxagliptin—Urticaria—Prednisone—prostate cancer	6.14e-05	0.000513	CcSEcCtD
Saxagliptin—Pruritus—Capecitabine—prostate cancer	6.14e-05	0.000513	CcSEcCtD
Saxagliptin—Abdominal pain—Prednisone—prostate cancer	6.11e-05	0.00051	CcSEcCtD
Saxagliptin—Anaphylactic shock—Epirubicin—prostate cancer	6.05e-05	0.000505	CcSEcCtD
Saxagliptin—Infection—Epirubicin—prostate cancer	6.01e-05	0.000502	CcSEcCtD
Saxagliptin—Dizziness—Docetaxel—prostate cancer	5.93e-05	0.000495	CcSEcCtD
Saxagliptin—Thrombocytopenia—Epirubicin—prostate cancer	5.92e-05	0.000494	CcSEcCtD
Saxagliptin—Skin disorder—Epirubicin—prostate cancer	5.88e-05	0.00049	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—prostate cancer	5.84e-05	0.000487	CcSEcCtD
Saxagliptin—Myalgia—Doxorubicin—prostate cancer	5.84e-05	0.000487	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.8e-05	0.000484	CcSEcCtD
Saxagliptin—Dizziness—Capecitabine—prostate cancer	5.74e-05	0.000479	CcSEcCtD
Saxagliptin—Vomiting—Docetaxel—prostate cancer	5.7e-05	0.000476	CcSEcCtD
Saxagliptin—Hypersensitivity—Prednisone—prostate cancer	5.7e-05	0.000476	CcSEcCtD
Saxagliptin—Rash—Docetaxel—prostate cancer	5.65e-05	0.000472	CcSEcCtD
Saxagliptin—Dermatitis—Docetaxel—prostate cancer	5.65e-05	0.000472	CcSEcCtD
Saxagliptin—Headache—Docetaxel—prostate cancer	5.62e-05	0.000469	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—prostate cancer	5.6e-05	0.000467	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—prostate cancer	5.56e-05	0.000464	CcSEcCtD
Saxagliptin—Asthenia—Prednisone—prostate cancer	5.55e-05	0.000463	CcSEcCtD
Saxagliptin—Vomiting—Capecitabine—prostate cancer	5.52e-05	0.000461	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.51e-05	0.00046	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—prostate cancer	5.48e-05	0.000457	CcSEcCtD
Saxagliptin—Rash—Capecitabine—prostate cancer	5.47e-05	0.000457	CcSEcCtD
Saxagliptin—Pruritus—Prednisone—prostate cancer	5.47e-05	0.000457	CcSEcCtD
Saxagliptin—Dermatitis—Capecitabine—prostate cancer	5.47e-05	0.000457	CcSEcCtD
Saxagliptin—Headache—Capecitabine—prostate cancer	5.44e-05	0.000454	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—prostate cancer	5.44e-05	0.000454	CcSEcCtD
Saxagliptin—Nausea—Docetaxel—prostate cancer	5.33e-05	0.000445	CcSEcCtD
Saxagliptin—Dyspepsia—Epirubicin—prostate cancer	5.32e-05	0.000444	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Epirubicin—prostate cancer	5.22e-05	0.000436	CcSEcCtD
Saxagliptin—Fatigue—Epirubicin—prostate cancer	5.21e-05	0.000435	CcSEcCtD
Saxagliptin—Nausea—Capecitabine—prostate cancer	5.16e-05	0.00043	CcSEcCtD
Saxagliptin—Dizziness—Prednisone—prostate cancer	5.11e-05	0.000427	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.1e-05	0.000426	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Epirubicin—prostate cancer	4.95e-05	0.000413	CcSEcCtD
Saxagliptin—Dyspepsia—Doxorubicin—prostate cancer	4.93e-05	0.000411	CcSEcCtD
Saxagliptin—Vomiting—Prednisone—prostate cancer	4.92e-05	0.00041	CcSEcCtD
Saxagliptin—Rash—Prednisone—prostate cancer	4.88e-05	0.000407	CcSEcCtD
Saxagliptin—Dermatitis—Prednisone—prostate cancer	4.87e-05	0.000407	CcSEcCtD
Saxagliptin—Headache—Prednisone—prostate cancer	4.84e-05	0.000404	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.83e-05	0.000403	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—prostate cancer	4.83e-05	0.000403	CcSEcCtD
Saxagliptin—Urticaria—Epirubicin—prostate cancer	4.81e-05	0.000401	CcSEcCtD
Saxagliptin—Abdominal pain—Epirubicin—prostate cancer	4.78e-05	0.000399	CcSEcCtD
Saxagliptin—Nausea—Prednisone—prostate cancer	4.59e-05	0.000383	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Doxorubicin—prostate cancer	4.58e-05	0.000382	CcSEcCtD
Saxagliptin—Hypersensitivity—Epirubicin—prostate cancer	4.46e-05	0.000372	CcSEcCtD
Saxagliptin—Urticaria—Doxorubicin—prostate cancer	4.45e-05	0.000371	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—prostate cancer	4.42e-05	0.000369	CcSEcCtD
Saxagliptin—Asthenia—Epirubicin—prostate cancer	4.34e-05	0.000362	CcSEcCtD
Saxagliptin—Pruritus—Epirubicin—prostate cancer	4.28e-05	0.000357	CcSEcCtD
Saxagliptin—Hypersensitivity—Doxorubicin—prostate cancer	4.12e-05	0.000344	CcSEcCtD
Saxagliptin—Asthenia—Doxorubicin—prostate cancer	4.02e-05	0.000335	CcSEcCtD
Saxagliptin—Dizziness—Epirubicin—prostate cancer	4e-05	0.000334	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—prostate cancer	3.96e-05	0.00033	CcSEcCtD
Saxagliptin—Vomiting—Epirubicin—prostate cancer	3.85e-05	0.000321	CcSEcCtD
Saxagliptin—Rash—Epirubicin—prostate cancer	3.81e-05	0.000318	CcSEcCtD
Saxagliptin—Dermatitis—Epirubicin—prostate cancer	3.81e-05	0.000318	CcSEcCtD
Saxagliptin—Headache—Epirubicin—prostate cancer	3.79e-05	0.000316	CcSEcCtD
Saxagliptin—Dizziness—Doxorubicin—prostate cancer	3.7e-05	0.000309	CcSEcCtD
Saxagliptin—Nausea—Epirubicin—prostate cancer	3.59e-05	0.0003	CcSEcCtD
Saxagliptin—Vomiting—Doxorubicin—prostate cancer	3.56e-05	0.000297	CcSEcCtD
Saxagliptin—Rash—Doxorubicin—prostate cancer	3.53e-05	0.000295	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—prostate cancer	3.53e-05	0.000294	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—prostate cancer	3.51e-05	0.000293	CcSEcCtD
Saxagliptin—Nausea—Doxorubicin—prostate cancer	3.32e-05	0.000277	CcSEcCtD
Saxagliptin—CYP3A5—Metabolism—GSTA3—prostate cancer	1.01e-05	0.000188	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—UCP3—prostate cancer	1.01e-05	0.000188	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP17A1—prostate cancer	9.96e-06	0.000186	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CASP9—prostate cancer	9.94e-06	0.000186	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.85e-06	0.000184	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.82e-06	0.000184	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PRKCQ—prostate cancer	9.63e-06	0.00018	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—HSD3B1—prostate cancer	9.6e-06	0.000179	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SLC22A3—prostate cancer	9.6e-06	0.000179	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—NCOA2—prostate cancer	9.49e-06	0.000177	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTA4—prostate cancer	9.2e-06	0.000172	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—TBXAS1—prostate cancer	9.2e-06	0.000172	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—FGF10—prostate cancer	9.15e-06	0.000171	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—SLC5A5—prostate cancer	9.05e-06	0.000169	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTA2—prostate cancer	8.97e-06	0.000168	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SULT1A1—prostate cancer	8.86e-06	0.000166	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ABCG5—prostate cancer	8.86e-06	0.000166	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP2E1—prostate cancer	8.84e-06	0.000165	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CBR1—prostate cancer	8.76e-06	0.000164	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CSAD—prostate cancer	8.76e-06	0.000164	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GRHL1—prostate cancer	8.76e-06	0.000164	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—TST—prostate cancer	8.76e-06	0.000164	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ADI1—prostate cancer	8.76e-06	0.000164	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PSAT1—prostate cancer	8.76e-06	0.000164	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—NQO1—prostate cancer	8.74e-06	0.000163	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TGFBR2—prostate cancer	8.71e-06	0.000163	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTA1—prostate cancer	8.65e-06	0.000162	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—TH—prostate cancer	8.62e-06	0.000161	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ITPR1—prostate cancer	8.57e-06	0.00016	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.56e-06	0.00016	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—HSD3B2—prostate cancer	8.55e-06	0.00016	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTO1—prostate cancer	8.55e-06	0.00016	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—NAT2—prostate cancer	8.55e-06	0.00016	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP3A4—prostate cancer	8.53e-06	0.000159	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.48e-06	0.000159	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP1B1—prostate cancer	8.38e-06	0.000157	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—LRP2—prostate cancer	8.2e-06	0.000153	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP2C18—prostate cancer	8.2e-06	0.000153	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PLCB2—prostate cancer	8.2e-06	0.000153	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—UGT2B15—prostate cancer	8.14e-06	0.000152	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GRHPR—prostate cancer	8.14e-06	0.000152	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—UGT2B17—prostate cancer	8.14e-06	0.000152	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CKMT2—prostate cancer	8.14e-06	0.000152	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GGT1—prostate cancer	8.12e-06	0.000152	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—P4HB—prostate cancer	8.04e-06	0.00015	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—NCOA1—prostate cancer	8e-06	0.000149	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP19A1—prostate cancer	7.88e-06	0.000147	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—LPL—prostate cancer	7.85e-06	0.000147	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SLC22A1—prostate cancer	7.82e-06	0.000146	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PDGFRB—prostate cancer	7.78e-06	0.000146	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NAGLU—prostate cancer	7.66e-06	0.000143	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SULT2B1—prostate cancer	7.66e-06	0.000143	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—RFK—prostate cancer	7.66e-06	0.000143	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—MBTPS1—prostate cancer	7.66e-06	0.000143	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTM3—prostate cancer	7.66e-06	0.000143	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—AOX1—prostate cancer	7.66e-06	0.000143	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PGAM2—prostate cancer	7.66e-06	0.000143	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SULT2A1—prostate cancer	7.62e-06	0.000143	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—RXRA—prostate cancer	7.61e-06	0.000142	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ERCC2—prostate cancer	7.52e-06	0.000141	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—MED12—prostate cancer	7.5e-06	0.00014	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GNG5—prostate cancer	7.44e-06	0.000139	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.4e-06	0.000138	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ERBB3—prostate cancer	7.36e-06	0.000138	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—FGFR2—prostate cancer	7.35e-06	0.000137	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—COMT—prostate cancer	7.33e-06	0.000137	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GSTP1—prostate cancer	7.29e-06	0.000136	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP3A43—prostate cancer	7.26e-06	0.000136	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—AMACR—prostate cancer	7.26e-06	0.000136	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—DEGS1—prostate cancer	7.26e-06	0.000136	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NAT1—prostate cancer	7.26e-06	0.000136	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SRD5A2—prostate cancer	7.26e-06	0.000136	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ITPR1—prostate cancer	7.17e-06	0.000134	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—NCOA3—prostate cancer	7.17e-06	0.000134	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MTHFR—prostate cancer	7.07e-06	0.000132	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.05e-06	0.000132	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TERT—prostate cancer	7.05e-06	0.000132	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—HSD17B1—prostate cancer	6.92e-06	0.000129	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—HPGDS—prostate cancer	6.84e-06	0.000128	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP2C19—prostate cancer	6.79e-06	0.000127	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—TYMS—prostate cancer	6.78e-06	0.000127	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HIF1A—prostate cancer	6.74e-06	0.000126	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GSTM1—prostate cancer	6.7e-06	0.000125	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTT1—prostate cancer	6.63e-06	0.000124	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ACHE—prostate cancer	6.63e-06	0.000124	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—LPL—prostate cancer	6.58e-06	0.000123	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP2A6—prostate cancer	6.56e-06	0.000123	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CAV1—prostate cancer	6.52e-06	0.000122	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—AKR1C3—prostate cancer	6.38e-06	0.000119	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP1A1—prostate cancer	6.35e-06	0.000119	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PRKACB—prostate cancer	6.34e-06	0.000119	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ERCC2—prostate cancer	6.3e-06	0.000118	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP17A1—prostate cancer	6.28e-06	0.000117	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—HPGD—prostate cancer	6.17e-06	0.000115	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.17e-06	0.000115	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—BAD—prostate cancer	6.13e-06	0.000115	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—NCOA2—prostate cancer	5.98e-06	0.000112	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—APC—prostate cancer	5.94e-06	0.000111	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—MTHFR—prostate cancer	5.92e-06	0.000111	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—EGF—prostate cancer	5.87e-06	0.00011	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—IRS1—prostate cancer	5.87e-06	0.00011	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PPARA—prostate cancer	5.81e-06	0.000109	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—TNFRSF21—prostate cancer	5.8e-06	0.000108	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SLC5A5—prostate cancer	5.71e-06	0.000107	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—GSK3B—prostate cancer	5.7e-06	0.000107	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.64e-06	0.000106	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—MTAP—prostate cancer	5.64e-06	0.000106	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—INS—prostate cancer	5.62e-06	0.000105	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP2E1—prostate cancer	5.57e-06	0.000104	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—NQO1—prostate cancer	5.51e-06	0.000103	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CREBBP—prostate cancer	5.51e-06	0.000103	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.5e-06	0.000103	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.5e-06	0.000103	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CAV1—prostate cancer	5.46e-06	0.000102	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—TH—prostate cancer	5.43e-06	0.000102	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP3A4—prostate cancer	5.37e-06	0.0001	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP1B1—prostate cancer	5.28e-06	9.88e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MAP2K1—prostate cancer	5.26e-06	9.83e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.25e-06	9.81e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ACSL4—prostate cancer	5.25e-06	9.81e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PIK3CD—prostate cancer	5.22e-06	9.76e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.22e-06	9.76e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SERPINE1—prostate cancer	5.17e-06	9.66e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GGT1—prostate cancer	5.12e-06	9.57e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—NCOA1—prostate cancer	5.04e-06	9.42e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PHGDH—prostate cancer	5.03e-06	9.4e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ARG2—prostate cancer	5.03e-06	9.4e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—UMPS—prostate cancer	5.03e-06	9.4e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—FGF2—prostate cancer	5e-06	9.35e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CG—prostate cancer	4.98e-06	9.3e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP19A1—prostate cancer	4.97e-06	9.29e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—LDHB—prostate cancer	4.93e-06	9.22e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—NOS3—prostate cancer	4.93e-06	9.22e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.84e-06	9.05e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—RXRA—prostate cancer	4.79e-06	8.96e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—JAK2—prostate cancer	4.79e-06	8.96e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—INS—prostate cancer	4.71e-06	8.8e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MDM2—prostate cancer	4.68e-06	8.75e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—UCP3—prostate cancer	4.68e-06	8.74e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—TCN2—prostate cancer	4.68e-06	8.74e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTA3—prostate cancer	4.68e-06	8.74e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PDHA1—prostate cancer	4.68e-06	8.74e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—COMT—prostate cancer	4.62e-06	8.64e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CREBBP—prostate cancer	4.61e-06	8.62e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ERBB2—prostate cancer	4.61e-06	8.62e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTP1—prostate cancer	4.6e-06	8.59e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PIK3CB—prostate cancer	4.55e-06	8.51e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ITPR1—prostate cancer	4.52e-06	8.46e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PTGS2—prostate cancer	4.51e-06	8.43e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.46e-06	8.34e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.46e-06	8.34e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CD—prostate cancer	4.37e-06	8.18e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.28e-06	8e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTA4—prostate cancer	4.28e-06	8e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—TYMS—prostate cancer	4.27e-06	7.99e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CDKN1B—prostate cancer	4.27e-06	7.99e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTM1—prostate cancer	4.22e-06	7.9e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTA2—prostate cancer	4.17e-06	7.79e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—LPL—prostate cancer	4.15e-06	7.75e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—NOS3—prostate cancer	4.13e-06	7.72e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ABCG5—prostate cancer	4.12e-06	7.7e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.12e-06	7.7e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CTNNB1—prostate cancer	4.04e-06	7.55e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTA1—prostate cancer	4.02e-06	7.52e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP1A1—prostate cancer	4e-06	7.49e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.98e-06	7.43e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NAT2—prostate cancer	3.98e-06	7.43e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTO1—prostate cancer	3.98e-06	7.43e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ERCC2—prostate cancer	3.97e-06	7.43e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CDKN1A—prostate cancer	3.94e-06	7.37e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PTEN—prostate cancer	3.93e-06	7.35e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CB—prostate cancer	3.81e-06	7.13e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—LRP2—prostate cancer	3.81e-06	7.13e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PLCB2—prostate cancer	3.81e-06	7.13e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.81e-06	7.13e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PTGS2—prostate cancer	3.78e-06	7.06e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—EP300—prostate cancer	3.75e-06	7.01e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—P4HB—prostate cancer	3.74e-06	6.99e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—MTHFR—prostate cancer	3.73e-06	6.98e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PPARA—prostate cancer	3.66e-06	6.85e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SRC—prostate cancer	3.65e-06	6.82e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.64e-06	6.8e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.54e-06	6.63e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—STAT3—prostate cancer	3.52e-06	6.58e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—MED12—prostate cancer	3.49e-06	6.52e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GNG5—prostate cancer	3.46e-06	6.47e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CAV1—prostate cancer	3.44e-06	6.44e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NCOA3—prostate cancer	3.33e-06	6.23e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PTEN—prostate cancer	3.29e-06	6.16e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MYC—prostate cancer	3.27e-06	6.11e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TGFB1—prostate cancer	3.26e-06	6.1e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—EGFR—prostate cancer	3.2e-06	5.98e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—HPGDS—prostate cancer	3.18e-06	5.94e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.16e-06	5.91e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—EP300—prostate cancer	3.14e-06	5.87e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.14e-06	5.86e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTT1—prostate cancer	3.08e-06	5.76e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ACHE—prostate cancer	3.08e-06	5.76e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.05e-06	5.7e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—KRAS—prostate cancer	3.02e-06	5.65e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—INS—prostate cancer	2.97e-06	5.55e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.96e-06	5.54e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PRKACB—prostate cancer	2.95e-06	5.51e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.92e-06	5.46e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CREBBP—prostate cancer	2.91e-06	5.44e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NCOA2—prostate cancer	2.78e-06	5.2e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PIK3CA—prostate cancer	2.77e-06	5.19e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.76e-06	5.16e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.65e-06	4.96e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—NOS3—prostate cancer	2.6e-06	4.87e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.59e-06	4.84e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NQO1—prostate cancer	2.56e-06	4.79e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—TH—prostate cancer	2.53e-06	4.72e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—IL6—prostate cancer	2.46e-06	4.59e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.46e-06	4.59e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.4e-06	4.49e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PTGS2—prostate cancer	2.38e-06	4.45e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GGT1—prostate cancer	2.38e-06	4.45e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NCOA1—prostate cancer	2.34e-06	4.38e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CA—prostate cancer	2.32e-06	4.34e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.31e-06	4.32e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—AKT1—prostate cancer	2.27e-06	4.24e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—RXRA—prostate cancer	2.23e-06	4.17e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—COMT—prostate cancer	2.15e-06	4.01e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTP1—prostate cancer	2.14e-06	4e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ITPR1—prostate cancer	2.1e-06	3.93e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PTEN—prostate cancer	2.08e-06	3.88e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—TYMS—prostate cancer	1.99e-06	3.71e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—EP300—prostate cancer	1.98e-06	3.7e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTM1—prostate cancer	1.96e-06	3.67e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—LPL—prostate cancer	1.93e-06	3.6e-05	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—AKT1—prostate cancer	1.9e-06	3.55e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.86e-06	3.48e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ERCC2—prostate cancer	1.85e-06	3.45e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—MTHFR—prostate cancer	1.74e-06	3.24e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PPARA—prostate cancer	1.7e-06	3.18e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CAV1—prostate cancer	1.6e-06	2.99e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.47e-06	2.74e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.46e-06	2.73e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—INS—prostate cancer	1.38e-06	2.58e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CREBBP—prostate cancer	1.35e-06	2.53e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.28e-06	2.4e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NOS3—prostate cancer	1.21e-06	2.26e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—AKT1—prostate cancer	1.2e-06	2.24e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.12e-06	2.09e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PTGS2—prostate cancer	1.11e-06	2.07e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PTEN—prostate cancer	9.66e-07	1.81e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—EP300—prostate cancer	9.21e-07	1.72e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.81e-07	1.27e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—AKT1—prostate cancer	5.56e-07	1.04e-05	CbGpPWpGaD
